RootPath Raises $7M to Bring Cancer Cell Therapy to Solid Tumors

The concept of turning a patient’s own immune cells into a cancer therapy has made strides, with the past year seeing FDA approvals of two such treatments for blood cancers. But these cell therapies don’t work for everyone, and they can cause dangerous side effects. They also haven’t yet worked on solid tumors.